Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Metastatic Breast Cancer: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

Access Activity

Overview / Abstract:


Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2019). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement eventually develop metastatic disease (Siegel et al, 2019; Mortensen et al, 2018). Women with MBC have a poorer prognosis than the overall population of breast cancer patients, and issues such as refractory or resistant disease, cumulative toxicities, adverse events, depression, and financial hardship are often encountered (Mortensen et al, 2018). Despite progress in understanding the pathogenesis of MBC and advances in therapy, the 5-year overall survival rate remains only 27% (Siegel et al, 2019).


Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of patients with MBC.


Upon completion of this activity, participants should be able to:

1.) Identify prognostic markers that impact treatment selection and treatment goals to individual patients with metastatic breast cancer (MBC)
2.) Evaluate the efficacy and safety profiles of novel therapies for HER2-positive, HER2-negative, and triple-negative MBC
3.) Assess strategies to manage treatment-related adverse events, promote adherence to therapy, and ensure patient-centered MBC care


Dec 27, 2021


Nurse Practitioner , Nursing CNE


Online, Webinar / Webcast / Video

Credits / Hours

1.25 NCPD



Presenters / Authors / Faculty

Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN (Chairperson)
Nurse Practitioner
Memorial Sloan Kettering Cancer Center

Activity Specialities / Related Topics

Pain Management, Oncology / Cancer / Radiation Therapy, OB/GYN / Women's Health, Medication Safety, Diagnosis / Assessment / Patient History, Adverse Drug Reactions / ADR

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from Bristol Myers Squibb and Eisai.

Keywords / Search Terms

i3 Health breast cancer, metastatic breast cancer, cancer, MBC, oncology, NCPD, CE, free NCPD, free CE, ILNA points, free ILNA points, i3 Health, online NCPD Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map